About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Ipca Laboratories Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Neuland Laboratories
17150.9
634.45
3.84
136.24
125.89
4712
16.42
0.07
1182.3
Astrazeneca Pharma I
9817.3
281.85
2.96
73.34
133.85
719
33.04
0.33
305.28
Wockhardt
1414.95
133.65
10.43
8.68
163.06
250837
8.22
0
169.88
Alkem Laboratories
5626.95
119.95
2.18
185.84
30.28
1596
-2.92
0.8
1030.68
Acutaas Chemicals
1811.8
88
5.11
27.57
65.73
24947
83.7
0.04
160.19
Abbott India
29083.4
80.15
0.28
683.45
42.55
511
-1.28
1.63
1978.48
Ajanta Pharma
2539.3
75.15
3.05
76.07
33.38
8160
-15.25
1.1
289.84
Jubilant Pharmova
1169.1
71.55
6.52
-1.57
0
16381
-6.65
0.43
144.98
Torrent Pharma
3628.15
69.05
1.94
58.21
62.33
1720
13.43
0.88
224.32
Glaxosmithkline Phar
2685.4
61.15
2.33
55.61
48.29
4444
2.78
2.01
115.94
Divi's Lab
6805.65
59.5
0.88
88
77.34
11005
15.44
0.44
562.08
Strides Pharma Scien
984.25
48.65
5.2
8.29
118.66
319814
-36.65
0.41
346.37
Orchid Pharma
768.65
42.75
5.89
18.85
40.79
39193
-44.89
0
261.06
Gland Pharma
1972.15
42.65
2.21
70.19
28.1
14300
22.51
0.91
592.08
NGL Fine-Chem
1545.45
42.35
2.82
29.06
53.19
220
-23.11
0.11
452.6
JB Chem & Pharma
1714.05
33.9
2.02
43.24
39.64
7698
-7.42
0.9
206.14
Albert David
883.95
33.35
3.92
11.02
80.18
700
-36.6
0.57
687.7
Solara Active Pharma
631.95
31.85
5.31
4.52
139.81
52506
-20.61
0
271.53
Hester Biosciences
1631.85
30
1.87
36.73
44.43
389
-31.98
0.43
398.6
RPG Life Sciences
2435.6
28.45
1.18
130.25
18.7
196
-5.34
0.99
320.8
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.